A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.

导出 OA

翻译打印收藏纠错

作者： Gil,Awada ^[1] ; Yanina,Jansen ^[2] ; Julia Katharina,Schwarze ^[1] ; Jens,Tijtgat ^[1] ; Lennert,Hellinckx ^[1] ; Odrade,Gondry ^[3] ; Sim,Vermeulen ^[3] ; Sarah,Warren ^[4] ; Kelly,Schats ^[5] ; Pieter-Jan,van Dam ^[5] ; Mark,Kockx ^[5] ; Marleen,Keyaerts ^[3] ; Hendrik,Everaert ^[3] ; Teofila,Seremet ^[1] ; Anne,Rogiers ^[6] ; Bart,Neyns ^[1]

作者单位： Department of Medical Oncology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium. ^[1] Department of Surgery, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium. ^[2] Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium. ^[3] NanoString Technologies, Seattle, WA 98109, USA. ^[4] HistoGeneX, 2610 Antwerp, Belgium. ^[5] Department of Psychiatry, Centre Hospitalier Universitaire Brugmann, 1020 Brussels, Belgium. ^[6]

关键词 advanced melanoma biomarkers immunotherapy multivariate analysis pembrolizumab

DOI 10.3390/cancers13020168

PMID 33418936

发布时间 2021-01-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交